A new bill proposed in the New York Assembly, A10104, aims to allow pets with certain medical conditions access to medical grade CBD oil via a licensed veterinarians prescription.
Natural pet supplement sales have nearly doubled between 2008 and 2014, with an increase in sales that have shown the U.S. retail market to be worth $1.6B.
The new bill will provide pets access to hemp derived, high quality, Cannabidiol, or better known to the public as CBD oil. CBD oil has been known as useful in pets treating separation anxiety, epilepsy and other various inflammatory conditions.
Bill A10104 currently rests in the hands of the New York Senate Health Committee for approval.
You may be interested
Aphria Inc. to Expand into Latin America with Proposed $193M Stock Acquisition of LATAM HoldingsEditor - July 17, 2018
Aphria Inc. (TSX: APH) (OTC: APHQF) announced this morning that the company has entered into a share purchase agreement with private company Scythian Biosciences, Inc. (TSXV: SCYB)…
Maricann Obtains Cannabis Manufacturing License in MaltaEditor - July 17, 2018
The Maricann Group (CSE: MARI) (OTCQB:MRRCF), a publicly traded cannabis company with operations in Canada and Germany, announced this morning that their application to for a cannabis manufacturing…
CCT Featured Interview with Ralph Risch Phylos Chief Operating OfficerEditor - July 17, 2018
Ralph Risch, COO, of Phylos is an experienced entrepreneur and business leader who has founded and successfully exited multiple companies in the high tech industry. He has…